Priority Date: 17.06.09 (US 20090218005P)

Anti-VEGF Antibodies and their uses

  • Application ID: EP14197237
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1127.69
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61, C07, and C12 J A Kemp is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 127 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 17.06.2009 - Priority Date (US 20090218005P)
  • 15.07.2015 - Publication A1 (EP2894167)